Skip to main content
SpringerLink
Log in

Mechanisms of Tumor-Associated T-Cell Tolerance

  • Chapter
Book cover Tumor-Induced Immune Suppression

  • 639 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adler, A. J. (2005). Peripheral tolerization of effector and memory T cells: implications for autoimmunity and tumor-immunity. Curr Immunol Rev 1: 21–28.

    Article  CAS  Google Scholar 

  • Adler, A. J., Huang, C. T., Yochum, G. S., Marsh, D. W., and Pardoll, D. M. (2000). In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions. J Immunol 164:649–655.

    PubMed  CAS  Google Scholar 

  • Adler, A. J., Marsh, D. W., Yochum, G. S., Guzzo, J. L., Nigam, A., Nelson, W. G., and Pardoll, D. M. (1998). CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen presenting cells. J Exp Med 187:1555–1564.

    Article  PubMed  CAS  Google Scholar 

  • Anderson, M. J., Shafer-Weaver, K., Greenberg, N. M., and Hurwitz, A. A. (2007). Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer. J Immunol 178:1268–1276.

    PubMed  CAS  Google Scholar 

  • Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z., Berzins, S. P., Turley, S. J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., and Mathis, D. (2002). Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401.

    Article  PubMed  CAS  Google Scholar 

  • Apostolou, I., and von Boehmer, H. (2004). In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401–1408.

    Article  PubMed  CAS  Google Scholar 

  • Bachmaier, K., Krawczyk, C., Kozieradzki, I., Kong, Y. Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A., Itie, A., Le, J., Ohashi, P. S., Sarosi, I., Nishina, H., Lipkowitz, S., and Penninger, J. M. (2000). Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403:211–216.

    Article  PubMed  CAS  Google Scholar 

  • Bannchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392:245–252.

    Article  CAS  Google Scholar 

  • Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., and Heath, W. R. (2002). The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196:1099–1104.

    Article  PubMed  CAS  Google Scholar 

  • Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., and Ahmed, R. (2003). Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9: 540–547.

    Article  PubMed  CAS  Google Scholar 

  • Bogen, B. (1996). Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Eur J Immunol 26:2671–2679.

    Article  PubMed  CAS  Google Scholar 

  • Bogen, B., Dembic, Z., and Weiss, S. (1993). Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J 12:357–363.

    PubMed  CAS  Google Scholar 

  • Bos, R., van Duikeren, S., van Hall, T., Kaaijk, P., Taubert, R., Kyewski, B., Klein, L., Melief, C. J., and Offringa, R. (2005). Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire. Cancer Res 65:6443–6449.

    Article  PubMed  CAS  Google Scholar 

  • Bouneaud, C., Kourilsky, P., and Bousso, P. (2000). Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13:829–840.

    Article  PubMed  CAS  Google Scholar 

  • Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., and Sawyers, C. L. (2004). Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33–39.

    Article  PubMed  CAS  Google Scholar 

  • Chen, M., Wang, Y. H., Wang, Y., Huang, L., Sandoval, H., Liu, Y. J., and Wang, J. (2006). Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160–1164.

    Article  PubMed  CAS  Google Scholar 

  • Chiller, J. M., Habicht, G. S., and Weigle, W. O. (1971). Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171:813–815.

    Article  PubMed  CAS  Google Scholar 

  • Coffey, D. S. (2001). Similarities of prostate and breast cancer: evolution, diet, and estrogens. Urology 57:31–38.

    Article  PubMed  CAS  Google Scholar 

  • Cosman, F., and Lindsay, R. (1999). Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418–434.

    Article  PubMed  CAS  Google Scholar 

  • Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr (1994). Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716–719.

    Article  PubMed  CAS  Google Scholar 

  • Croft, M., Bradley, L. M., and Swain, S. L. (1994). Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 152:2675–2685.

    PubMed  CAS  Google Scholar 

  • Denmeade, S. R., and Isaacs, J. T. (2002). A history of prostate cancer treatment. Nat Rev Cancer 2:389–396.

    Article  PubMed  CAS  Google Scholar 

  • Derbinski, J., Gabler, J., Brors, B., Tierling, S., Jonnakuty, S., Hergenhahn, M., Peltonen, L., Walter, J., and Kyewski, B. (2005). Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 202:33–45.

    Article  PubMed  CAS  Google Scholar 

  • Doan, T., Herd, K. A., Lambert, P. F., Fernando, G. J., Street, M. D., and Tindle, R. W. (2000). Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization. Cancer Res 60:2810–2815.

    PubMed  CAS  Google Scholar 

  • Drake, C. G., Doody, A. D., Mihalyo, M. A., Huang, C. T., Kelleher, E., Ravi, S., Hipkiss, E. L., Flies, D. B., Kennedy, E. P., Long, M., McGary, P. W., Coryell, L., Nelson, W. G., Pardoll, D. M., and Adler, A. J. (2005). Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer Cell 7:239–249.

    Article  PubMed  CAS  Google Scholar 

  • Dresser, D. W. (1962). Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology 5:378–388.

    PubMed  CAS  Google Scholar 

  • D’Souza, W. N., and Lefrancois, L. (2003). IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J Immunol 171:5727–5735.

    PubMed  CAS  Google Scholar 

  • Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., Robinson, M. R., Raffeld, M., Duray, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., Mavroukakis, S. A., White, D. E., and Rosenberg, S. A. (2002). Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850–854.

    Article  PubMed  CAS  Google Scholar 

  • Dummer, W., Niethammer, A. G., Baccala, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., and Theofilopoulos, A. N. (2002). T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110:185–192.

    Article  PubMed  CAS  Google Scholar 

  • Eynon, E. E., and Parker, D. C. (1992). Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 175:131–138.

    Article  PubMed  CAS  Google Scholar 

  • Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C., and Morris, S. C. (1996). Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 157:1406–1414.

    PubMed  CAS  Google Scholar 

  • Fox, H. S. (1992). Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 175:1409–1412.

    Article  PubMed  CAS  Google Scholar 

  • Fuchs, E. J., and Matzinger, P. (1992). B cells turn off virgin but not memory T cells. Science 258:1156–1159.

    Article  PubMed  CAS  Google Scholar 

  • Furuya, Y., Lin, X. S., Walsh, J. C., Nelson, W. G., and Isaacs, J. T. (1995). Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136:1898–1906.

    Article  PubMed  CAS  Google Scholar 

  • Glimcher, L. H., Townsend, M. J., Sullivan, B. M., and Lord, G. M. (2004). Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4:900–911.

    Article  PubMed  CAS  Google Scholar 

  • Gorelik, E. (1983). Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res 39:71–120.

    PubMed  CAS  Google Scholar 

  • Gorelik, L., and Flavell, R. A. (2000). Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171–181.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439–3443.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, P. D., and Cheever, M. A. (1984). Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells. J Immunol 133:3401–3407.

    PubMed  CAS  Google Scholar 

  • Hagymasi, A. T., Slaiby, A. M., Mihalyo, M. A., Qui, H. Z., Zammit, D. J., Lefrancois, L., and Adler, A. J. (2007). Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naïve and Th1 effector CD4 cells. J Immunol 179:1524–1531.

    PubMed  CAS  Google Scholar 

  • Hakimi, J. M., Rondinelli, R. H., Schoenberg, M. P., and Barrack, E. R. (1996). Androgen-receptor gene structure and function in prostate cancer. World J Urol 14:329–337.

    Article  PubMed  CAS  Google Scholar 

  • Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., Demayo, F. J., Tilley, W., and Greenberg, N. M. (2005). Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci USA 102:1151–1156.

    Article  PubMed  CAS  Google Scholar 

  • Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., and Allen, P. M. (2000). Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity 13:265–276.

    Article  PubMed  CAS  Google Scholar 

  • Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., and Nussenzweig, M. C. (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769–779.

    Article  PubMed  CAS  Google Scholar 

  • Higgins, A. D., Mihalyo, M. A., and Adler, A. J. (2002a). Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen. J Immunol 169:3622–3629.

    CAS  Google Scholar 

  • Higgins, A. D., Mihalyo, M. A., McGary, P. W., and Adler, A. J. (2002b). CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement. J Immunol 168:5573–5581.

    CAS  Google Scholar 

  • Horgan, K. J., Van Seventer, G. A., Shimizu, Y., and Shaw, S. (1990). Hyporesponsiveness of “naive” (CD45RA+) human T cells to multiple receptor-mediated stimuli but augmentation of responses by co-stimuli. Eur J Immunol 20:1111–1118.

    Article  PubMed  CAS  Google Scholar 

  • Hu, H. M., Poehlein, C. H., Urba, W. J., and Fox, B. A. (2002). Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res 62:3914–3919.

    PubMed  CAS  Google Scholar 

  • Hu, J., Kindsvogel, W., Busby, S., Bailey, M. C., Shi, Y., and Greenberg, P. D. (1993). An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues. J Exp Med 177:1681–1690.

    Article  PubMed  CAS  Google Scholar 

  • Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., and Levitsky, H. (1998). The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 188:2357–2368.

    Article  PubMed  CAS  Google Scholar 

  • Ikeda, H., Old, L. J., and Schreiber, R. D. (2002). The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13:95–109.

    Article  PubMed  CAS  Google Scholar 

  • Janeway, C. A., Jr, and Medzhitov, R. (2002). Innate immune recognition. Annu Rev Immunol 20:197–216.

    Article  PubMed  CAS  Google Scholar 

  • Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., and Thun, M. J. (2005). Cancer statistics, 2005. CA Cancer J Clin 55:10–30.

    PubMed  Google Scholar 

  • Jenkins, M. K., Khoruts, A., Ingulli, E., Mueller, D. L., McSorley, S. J., Reinhardt, R. L., Itano, A., and Pape, K. A. (2001). In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 19:23–45.

    Article  PubMed  CAS  Google Scholar 

  • Jones, L. A., Chin, L. T., Longo, D. L., and Kruisbeek, A. M. (1990). Peripheral clonal elimination of functional T cells. Science 250:1726–1729.

    Article  PubMed  CAS  Google Scholar 

  • Jooss, K., Gjata, B., Danos, O., von Boehmer, H., and Sarukhan, A. (2001). Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci USA 98:8738–8743.

    Article  PubMed  CAS  Google Scholar 

  • Kamath, A. T., Henri, S., Battye, F., Tough, D. F., and Shortman, K. (2002). Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100:1734–1741.

    PubMed  CAS  Google Scholar 

  • Kappler, J., Roehm, M., and Marrack, P. (1987). T cell tolerance by clonal elimination in the thymus. Cell 49:273–280.

    Article  PubMed  CAS  Google Scholar 

  • Kearney, E. R., Pape, K. A., Loh, D. Y., and Jenkins, M. K. (1994). Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327–339.

    Article  PubMed  CAS  Google Scholar 

  • Kisielow, P., Bluthmann, H., Staerz, U. D., Steinmetz, M., and von Boehmer, H. (1988). Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742–746.

    Article  PubMed  CAS  Google Scholar 

  • Kreuwel, H. T., Aung, S., Silao, C., and Sherman, L. A. (2002). Memory CD8(+) T cells undergo peripheral tolerance. Immunity 17:73–81.

    Article  PubMed  CAS  Google Scholar 

  • Kurts, C., Cannarile, M., Klebba, I., and Brocker, T. (2001). Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J Immunol 166:1439–1442.

    PubMed  CAS  Google Scholar 

  • Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., and Heath, W. R. (1997). Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J Exp Med 186:239–245.

    Article  PubMed  CAS  Google Scholar 

  • Kurts, C., Miller, J. F. A. P., Subramaniam, R. M., Carbone, F. R., and Heath, W. R. (1998). Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 188:409–414.

    Article  PubMed  CAS  Google Scholar 

  • Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., Roederer, M., and Davis, M. M. (1999). Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5:677–685.

    Article  PubMed  CAS  Google Scholar 

  • Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396:643–649.

    Article  PubMed  CAS  Google Scholar 

  • Liblau, R., Tisch, R., Bercovici, N., and McDevitt, H. (1997). Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol Today 18:599–604.

    Article  PubMed  CAS  Google Scholar 

  • Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., and Steinman, R. M. (2002). Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196:1091–1097.

    Article  PubMed  CAS  Google Scholar 

  • Long, M., Higgins, A. D., Mihalyo, M. A., and Adler, A. J. (2003). Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentials. Cell Immunol 224:114–121.

    Article  PubMed  CAS  Google Scholar 

  • Long, M., Slaiby, A. M., Hagymasi, A. T., Mihalyo, M. A., Lichtler, A. C., Reiner, S. L., and Adler, A. J. (2006). T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression. J Immunol 176:1036–1045.

    PubMed  CAS  Google Scholar 

  • Lopez-Otin, C., and Diamandis, E. P. (1998). Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 19:365–396.

    Article  PubMed  CAS  Google Scholar 

  • Lyman, M. A., Aung, S., Biggs, J. A., and Sherman, L. A. (2004). A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL. J Immunol 172:6558–6567.

    PubMed  CAS  Google Scholar 

  • Marzo, A. L., Lake, R. A., Lo, D., Sherman, L., McWilliam, A., Nelson, D., Robinson, B. W., and Scott, B. (1999). Tumor antigens are constitutively presented in the draining lymph nodes. J Immunol 162:5838–5845.

    PubMed  CAS  Google Scholar 

  • Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045.

    PubMed  CAS  Google Scholar 

  • Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135–145.

    Article  PubMed  CAS  Google Scholar 

  • Mihalyo, M. A., Doody, A. D., McAleer, J. P., Nowak, E. C., Long, M., Yang, Y., and Adler, A. J. (2004). In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy. J Immunol 172: 5338–5345.

    PubMed  CAS  Google Scholar 

  • Mihalyo, M. A., Hagymasi, A. T., Slaiby, A. M., Nevius, E. E., and Adler, A. J. (2007). Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis. Prostate 67:536–546.

    Article  PubMed  Google Scholar 

  • Morgan, D. J., Kreuwel, H. T., Fleck, S., Levitsky, H. I., Pardoll, D. M., and Sherman, L. A. (1998). Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity. J Immunol 160:643–651.

    PubMed  CAS  Google Scholar 

  • Mueller, D. L. (2004). E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 5:883–890.

    Article  PubMed  CAS  Google Scholar 

  • Murphy, K. M., and Reiner, S. L. (2002). Decision making in the immune system: the lineage decisions of helper T cells. Nat Rev Immunol 2:933–944.

    Article  PubMed  CAS  Google Scholar 

  • Nguyen, L. T., Elford, A. R., Murakami, K., Garza, K. M., Schoenberger, S. P., Odermatt, B., Speiser, D. E., and Ohashi, P. S. (2002). Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med 195:423–435.

    Article  PubMed  CAS  Google Scholar 

  • North, R. J. (1982). Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155: 1063–1074.

    Article  PubMed  CAS  Google Scholar 

  • Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., and Zinkernagel, R. M. (2001). Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411:1058–1064.

    Article  PubMed  CAS  Google Scholar 

  • Oldstone, M. B. (1998). Molecular mimicry and immune-mediated diseases. FASEB J 12:1255–1265.

    PubMed  CAS  Google Scholar 

  • Pape, K. A., Merica, R., Mondino, A., Khoruts, A., and Jenkins, M. K. (1998). Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J Immunol 160:4719–4729.

    PubMed  CAS  Google Scholar 

  • Pardoll, D. (2003). Does the immune system see tumors as foreign or self? Annu Rev Immunol 21:807–839.

    Article  PubMed  CAS  Google Scholar 

  • Poehlein, C. H., Hu, H. M., Yamada, J., Assmann, I., Alvord, W. G., Urba, W. J., and Fox, B. A. (2003). TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells. J Immunol 170:2004–2013.

    PubMed  CAS  Google Scholar 

  • Proietti, E., Greco, G., Garrone, B., Baccarini, S., Mauri, C., Venditti, M., Carlei, D., and Belardelli, F. (1998). Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. J Clin Invest 101: 429–441.

    Article  PubMed  CAS  Google Scholar 

  • Qin, Z., and Blankenstein, T. (2000). CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 12:677–686.

    Article  PubMed  CAS  Google Scholar 

  • Ramsdell, F., and Fowlkes, B. J. (1992). Maintenance of in vivo tolerance by persistence of antigen. Science 257:1130–1134.

    Article  PubMed  CAS  Google Scholar 

  • Rocha, B., and von Boehmer, H. (1991). Peripheral selection of the T cell repertoire. Science 251:1225–1228.

    Article  PubMed  CAS  Google Scholar 

  • Roden, A. C., Moser, M. T., Tri, S. D., Mercader, M., Kuntz, S. M., Dong, H., Hurwitz, A. A., McKean, D. J., Celis, E., Leibovich, B. C., Allison, J. P., and Kwon, E. D. (2004). Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 173:6098–6108.

    PubMed  CAS  Google Scholar 

  • Rosenberg, S. A., Yang, J. C., and Restifo, N. P. (2004). Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909–915.

    Article  PubMed  CAS  Google Scholar 

  • Roubinian, J. R., Talal, N., Greenspan, J. S., Goodman, J. R., and Siiteri, P. K. (1978). Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 147:1568–1583.

    Article  PubMed  CAS  Google Scholar 

  • Sagerstrom, C. G., Kerr, E. M., Allison, J. P., and Davis, M. M. (1993). Activation and differentiation requirements of primary T cells in vitro. Proc Natl Acad Sci USA 90:8987–8991.

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi, S. (2000). Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458.

    Article  PubMed  CAS  Google Scholar 

  • Schell, T. D., Knowles, B. B., and Tevethia, S. S. (2000). Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas. Cancer Res 60:3002–3012.

    PubMed  CAS  Google Scholar 

  • Schiavoni, G., Mattei, F., Di Pucchio, T., Santini, S. M., Bracci, L., Belardelli, F., and Proietti, E. (2000). Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Blood 95:2024–2030.

    PubMed  CAS  Google Scholar 

  • Schwartz, R. H. (2003). T cell anergy. Annu Rev Immunol 21:305–334.

    Article  PubMed  CAS  Google Scholar 

  • Sebzda, E., Wallace, V. A., Mayer, J., Yeung, R. S., Mak, T. W., and Ohashi, P. S. (1994). Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615–1618.

    Article  PubMed  CAS  Google Scholar 

  • Shevach, E. M. (2001). Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193:F41–F46.

    Google Scholar 

  • Shrikant, P., Khoruts, A., and Mescher, M. F. (1999). CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. Immunity 11:483–493.

    Article  PubMed  CAS  Google Scholar 

  • Sotomayor, E. M., Borrello, I., Rattis, F. M., Cuenca, A. G., Abrams, J., Staveley-O’Carroll, K., and Levitsky, H. I. (2001). Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. Blood 98:1070–1077.

    Article  PubMed  CAS  Google Scholar 

  • Spiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y. X., and Schreiber, H. (2002). Increasing tumor antigen expression overcomes “ignorance” to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 17:737–747.

    Article  PubMed  CAS  Google Scholar 

  • Srivastava, P. K. (2006). Therapeutic cancer vaccines. Curr Opin Immunol 18:201–205.

    Article  PubMed  CAS  Google Scholar 

  • Stavely-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., and Levitsky, H. (1998). Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci USA 95:1178–1183.

    Article  Google Scholar 

  • Steinman, R. M., Turley, S., Mellman, I., and Inaba, K. (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411–416.

    Article  PubMed  CAS  Google Scholar 

  • Sugimura, Y., Cunha, G. R., and Donjacour, A. A. (1986). Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. Biol Reprod 34:973–983.

    Article  PubMed  CAS  Google Scholar 

  • Surh, C. D., and Sprent, J. (1994). T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100–103.

    Article  PubMed  CAS  Google Scholar 

  • Sutherland, J. S., Goldberg, G. L., Hammett, M. V., Uldrich, A. P., Berzins, S. P., Heng, T. S., Blazar, B. R., Millar, J. L., Malin, M. A., Chidgey, A. P., and Boyd, R. L. (2005). Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 175:2741–2753.

    PubMed  CAS  Google Scholar 

  • Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541–547.

    Article  PubMed  CAS  Google Scholar 

  • Topalian, S. L., Solomon, D., and Rosenberg, S. A. (1989). Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142:3714–3725.

    PubMed  CAS  Google Scholar 

  • Viselli, S. M., Stanziale, S., Shults, K., Kovacs, W. J., and Olsen, N. J. (1995). Castration alters peripheral immune function in normal male mice. Immunology 84:337–342.

    PubMed  CAS  Google Scholar 

  • von Budingen, H. C., Tanuma, N., Villoslada, P., Ouallet, J. C., Hauser, S. L., and Genain, C. P. (2001). Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 21:155–170.

    Article  Google Scholar 

  • Wang, R. F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S. A. (1996). Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 184:2207–2216.

    Article  PubMed  CAS  Google Scholar 

  • Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., Dalton, W., Jove, R., Pardoll, D., and Yu, H. (2004). Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10:48–54.

    Article  PubMed  CAS  Google Scholar 

  • Webb, S., Morris, C., and Sprent, J. (1990). Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249–1256.

    Article  PubMed  CAS  Google Scholar 

  • Whitmore, W. F., and Gittes, R. F. (1977). Studies on the prostate and testis as immunologically privileged sites. Cancer Treat Rep 61:217–222.

    PubMed  CAS  Google Scholar 

  • Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K. H., and Boon, T. (1994). Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759–764.

    Article  PubMed  CAS  Google Scholar 

  • Yee, C., Riddell, S. R., and Greenberg, P. D. (1997). Prospects for adoptive T cell therapy. Curr Opin Immunol 9:702–708.

    Article  PubMed  CAS  Google Scholar 

  • Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., and Greenberg, P. D. (2002). Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 99:16168–16173.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, X. Y., Malloy, P. J., Krishnan, A. V., Swami, S., Navone, N. M., Peehl, D. M., and Feldman, D. (2000). Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 6:703–706.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, G., Drake, C. G., and Levitsky, H. I. (2006). Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107:628–636.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, G., Lu, Z., McCadden, J. D., Levitsky, H. I., and Marson, A. L. (2004). Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression. J Exp Med 200:1581–1592.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Immunotherapy of Cancer and Infectious Diseases and Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030-1601, USA

    Adam J. Adler

Authors
  1. Adam J. Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA

    Dmitry I. Gabrilovich

  2. Laboratory of Molecular Immunoregulation, National Cancer Institute, Frederick, MD 21071, USA

    Arthur A. Hurwitz

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Adler, A.J. (2008). Mechanisms of Tumor-Associated T-Cell Tolerance. In: Gabrilovich, D.I., Hurwitz, A.A. (eds) Tumor-Induced Immune Suppression. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69118-3_2

Download citation

Publish with us

Policies and ethics

Search

Navigation